April 2022 Br J Cardiol 2022;29:55–9 doi:10.5837/bjc.2022.011
Saad Ahmad, Shwe Win Hlaing, Muhammad Haris, Nadeem Attar
Background and history In recent times, medical marijuana has been a popular topic that has necessitated legal regulation. Annual prevalence of marijuana consumption in 2017 was 147 million or roughly 2.5% worldwide,1 making it the most widely grown, distributed and consumed recreational drug. The cannabis plant as botanical product has 480 natural components, 66 of which are classified as cannabinoids. The most commonly studied component, delta-9-tetrahydrocannabinol (THC) interacts with internal cannabinoid (CB) receptors of the human body. This activates an intricate physiological cascade, i.e. the endocannabinoid system described by Raph
August 2017 Br J Cardiol 2017;24:95–6
BJCardio Staff
Improvements in patient care mean hundreds more people are surviving heart failure, a new independent study has found. The latest report from the National Heart Failure Audit (April 2015– March 2016) (link below) has found that the mortality rate for people admitted to hospital with heart failure has dropped from 9.6% the previous year to 8.9%. The reduction in the mortality rate means that in the region of 500 lives have been saved in the past year compared to 2014–15. An assessment of patients admitted to hospital with heart failure at NHS Trusts also shows that more people are being provided with crucial medicines for heart disease as
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits